European pharmaceutical industry continues to invest in technology

November 2 2009

Gouda, the Netherlands - Imtech (technical services provider in Europe) has recently won contracts totalling about 31 million euro to deliver high-tech technological solutions for various pharmaceutical companies in Europe. Imtech notices that the European pharmaceutical industry continues to invest structurally in innovative technology.

Imtech CEO René van der Bruggen: ‘Imtech possesses virtually unique technical competences in the fields of air treatment, clean room solutions, energy technology, electrical engineering and instrumentation. Even during economically difficult circumstances we see that the European pharmaceutical industry’s demand for these high-tech solutions stays buoyant. That is why this industry remains an important segment for Imtech. Not in the least because various Imtech companies are increasingly co-operating with each other, which in turn leads to synergy and further growth.’

Merck Serono
For Merck Serono at Corsier-sur-Vevey in Switzerland - the principal biotechnical production site of Merck Serono - Imtech (Imtech Deutschland) is providing the high-tech technical infrastructure for the expansion of a biotechnical research and production building. This extension consists of 19 different parts, all dedicated to the specialised treatment of cancer. Among other things Imtech is delivering sustainable energy solutions, innovative air treatment and climate technology, specialised clean room solutions and an extremely efficient heat recovery system that re-uses 70% of the hourly production of 315,000 m3 of air in order to heat the building and to support the primary biotechnical production processes. This includes the use of high-tech heating pumps in combination with evaporation technology, compressed air, water-cooled compressors, absorption driers and redundant cooling. With 4,400 hardware and 8,000 software modules for measurement and control, Imtech is integrating all the technical facilities to deliver a smoothly working total solution.

GlaxoSmithKline Biologicals
For the GlaxoSmithKline Biologicals sites in Saint-Amand-les-Eaux and Notre-Dame-de-Bondeville in France, Wavre in Belgium and in Singapore, Imtech (Imtech Deutschland) is providing innovative air treatment solutions in special pharmaceutical isolators that are deployed to use conditioned air (with optimum air humidity, pressure and temperature geared to the primary processes of GlaxoSmithKline Biologicals) for sterilisation of parts of the production process.

Wyeth Medica and Millipore
For Wyeth Medica Ireland, a pharmaceutical company acquired by Pfizer, Imtech (Imtech Deutschland together with Suir Engineering, Imtech’s Irish specialist in electrical engineering and instrumentation) is providing the complete technological equipment of several clean rooms and research laboratories. The co-operation within the Imtech Group enables to deliver an attractive total solution to the customer. For the Irish Millipore, a supplier of special medical products for bioscientific research and biopharmaceutical production, Imtech (Suir Engineering) is providing all the electrical solutions needed for a high-tech facility that can separate molecules from each other.